Fox Run Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,309	Closed	-$68.6K	–	1005
2024 Q4	$68.6K	Buy	+12,309	New	+$68.6K	0.01%	825
2023 Q4	–	Sell	-12,162	Closed	-$155K	–	816
2023 Q3	$155K	Buy	+12,162	New	+$155K	0.05%	597